Xenon Pharmaceuticals, Inc. (XENE)
43.46
-0.06
(-0.14%)
USD |
NASDAQ |
Dec 10, 16:00
43.46
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Market Cap: 3.358B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 104.62M |
| Aurinia Pharmaceuticals, Inc. | 2.042B |
| Edesa Biotech, Inc. | 12.58M |
| Lexaria Bioscience Corp. | 26.00M |
| ProMIS Neurosciences, Inc. | 19.35M |
Market Cap Related Metrics
| PS Ratio | 456.73 |
| PEG Ratio | -0.2921 |
| Price to Book Value | 6.002 |
| Price | 43.46 |
| Earnings Yield | -8.94% |
| PEGY Ratio | -0.2921 |